Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Legend Biotech Corporation American Depositary Shares | LEGN

Daily Technical Analysis of Legend Biotech Corporation American Depositary Shares

Legend Biotech had a nice pop today and is currently up 4.53% we'll see if the cash keeps flowing in.

It looks like Legend Biotech isn't currently at a very decisive point in regards to support/resistance levels. Legend Biotech hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. LEGN might find some support at the 39.5 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-11-13

Analyst Ratings for Legend Biotech By Price Target And Rating

The analysts feel fairly neutral on the prospects for Legend Biotech but a little more positive than negative. The current Analysts Sentiment Score is 27.67. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-04-16 HC Wainwright reiterated their rating of Buy and added a price target of $87.00. Cantor Fitzgerald announced that they are initiating coverage with a rating of Overweight on 2024-04-03 and they set their price target at $82.00.On 2024-03-18 UBS Group increased their price target by 6.58% to $81.00. Raymond James initiated a rating of Outperform on 2024-03-13 and added a price target of $86.00. Royal Bank of Canada announced that they are reiterating a rating of Outperform on 2024-03-07 and added a price target of $85.00. On 2024-01-24 Barclays increased their price target by 1.08% to $94.00. On 2023-12-19 Scotiabank started covering Legend Biotech with a rating of Sector Perform and they set their price target at $65.00.The Goldman Sachs Group initiated a rating of Buy on 2023-11-06 and provided a price target of $90.09. Citigroup initiated a rating of Buy on 2023-08-02. Morgan Stanley gave a boost to their price target and moved to $85.00 from $65.00 on 2023-07-20.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
LEGN27.6730.06025.72-0.45

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-19)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
LEGN0.000.00

Short interest for Legend Biotech

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
LEGN9.49%2.4717516.111.6168160000

Social Sentiment for Legend Biotech

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
LEGN

Companies with the highest correlation to Legend Biotech

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
ZLAB | Zai Lab Limited American 0.660.31-1.65-20.9539.8237.62-4.3443106.0639.2326.06-2090.40-12477.05003.79084
ADPT | Adaptive Biotechnologies 0.62-1.34-20.79-2.21-2.0028.124.746850.6948.4522.42-4764.60-10994.7315007.83993
NVCR | NovoCure Limited Ordinary0.62.311.752.99-14.55-24.4337.8663-1.41-3.15-10.35-32666.69-9422.70007.02893
NOAH | Noah Holdings Limited0.57-0.172.54-6.1059.62-16.90-13.723417.079.3819.51-8410.83-1923.35003.60295
IOVA | Iovance Biotherapeutics, 0.54-0.61-5.24-22.92-28.16-20.6657.452010.1312.8812.48-7782.48186.720015.0071

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-